NASDAQ · KARD

Kardigan, Inc.

$21.23 +$0.49 (+2.36%) 1D After hours
Charting by TradingView

Key Metrics

$1.85B
Market cap
—
P/E · TTM
—
Revenue · TTM
—
Net income
EPS · TTM —
Dividend yield —
Free cash flow —
Beta · 1Y —
EBITDA · TTM —
Gross margin —

Snapshot

Market cap$1.85B
Enterprise value—
Shares outstanding89.3M
52-wk range$16.25 – $27.00
Avg volume · 20D681.1K
Net cash —
Book value / share—
ExchangeNASDAQ
About Kardigan, Inc.
IPO dateJun 18, 2026
Employees—

Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E—
P/S—
P/FCF—
EV/EBITDA—
EV/Sales—
Graham №—

Profitability

Gross —
Operating —
Net —
FCF —
ROE / ROIC — · —

Financial Health

Current ratio—
Quick ratio—
Debt / equity—
Debt / EBITDA —
Net cash —
Working capital—

Cash Flow · TTM

Operating CF —
Capex —
Free cash flow —
Buybacks —
Dividends paid —
Shareholder yield —

Piotroski F-Score

—
Needs two fiscal years of filings

Altman Z-Score

—
Insufficient balance-sheet inputs

Graham Number vs Price

—
Requires positive earnings and book value